Free Trial
OTCMKTS:TSOI

Therapeutic Solutions International (TSOI) Stock Price, News & Analysis

Therapeutic Solutions International logo
$0.0001 0.00 (-50.00%)
As of 04/25/2025 03:44 PM Eastern

About Therapeutic Solutions International Stock (OTCMKTS:TSOI)

Key Stats

Today's Range
$0.0001
$0.0002
50-Day Range
N/A
52-Week Range
$0.0001
$0.0011
Volume
25.82 million shs
Average Volume
35.10 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Therapeutic Solutions International, Inc. focuses on immune modulation for the treatment of various specific diseases in the United States. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, and traumatic brain injury, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production. It also produces nutraceuticals, including ProJuvenol, a synergistic blend of complex anti-aging ingredients in capsules; NanoStilbene, a nanoemulsion of nanoparticle pterostilbene; DermalStilbene, a topical form of pterostilbene delivered through spray application onto skin; IsoStilbene, an injectable formulation of pterostilbene; NeuroStilbene, an intranasal form of pterostilbene; NanoPSA, a blend of NanoStilbene and broccoli sprout extracts; and NLRP3 Trifecta, a two-product combo that consists of one bottle of NanoPSA and one bottle of GTE-50 green tea extract. In addition, the company develops therapeutics in chronic traumatic encephalopathy, and traumatic brain injury and lung pathology; and portfolio of immunotherapies that provides dendritic cell vaccines for cancers to Parkinson's disease developed on StemVacs platform. Therapeutic Solutions International, Inc. was founded in 2007 and is headquartered in Elk City, Idaho.

Therapeutic Solutions International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
0th Percentile Overall Score

TSOI MarketRank™: 

Therapeutic Solutions International scored higher than 0% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Therapeutic Solutions International.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Therapeutic Solutions International is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Therapeutic Solutions International is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Therapeutic Solutions International has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • Dividend Yield

    Therapeutic Solutions International does not currently pay a dividend.

  • Dividend Growth

    Therapeutic Solutions International does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Therapeutic Solutions International has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

  • News Coverage This Week

    MarketBeat has tracked 1 news article for Therapeutic Solutions International this week, compared to 0 articles on an average week.
Receive TSOI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Therapeutic Solutions International and its competitors with MarketBeat's FREE daily newsletter.

TSOI Stock News Headlines

Therapeutic Solutions International to Voluntarily Delist
Here’s How to Claim Your Stake in Elon’s Private Company, xAI
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

TSOI Stock Analysis - Frequently Asked Questions

Therapeutic Solutions International's stock was trading at $0.0002 at the beginning of 2025. Since then, TSOI shares have decreased by 50.0% and is now trading at $0.0001.
View the best growth stocks for 2025 here
.

Shares of TSOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Therapeutic Solutions International investors own include Creative Medical Technology (CELZ), Hon Hai Precision Industry (HNHPF), Zevra Therapeutics (ZVRA), CAS Medical Systems (CASM), CRISPR Therapeutics (CRSP), Trevena (TRVN) and Alamos Gold (AGI).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:TSOI
Fax
N/A
Employees
3
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (OTCMKTS:TSOI) was last updated on 4/26/2025 by MarketBeat.com Staff
From Our Partners